Product NDC: | 0378-5550 |
Proprietary Name: | Ropinirole Hydrochloride |
Non Proprietary Name: | ropinirole |
Active Ingredient(s): | .5 mg/1 & nbsp; ropinirole |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0378-5550 |
Labeler Name: | Mylan Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078881 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120815 |
Package NDC: | 0378-5550-01 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0378-5550-01) |
NDC Code | 0378-5550-01 |
Proprietary Name | Ropinirole Hydrochloride |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0378-5550-01) |
Product NDC | 0378-5550 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ropinirole |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20120815 |
Marketing Category Name | ANDA |
Labeler Name | Mylan Pharmaceuticals Inc. |
Substance Name | ROPINIROLE HYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Dopamine Agonists [MoA],Nonergot Dopamine Agonist [EPC] |